InsiderTrades.com logo
The Weight Loss Pill That Could Disrupt a $32 Billion Industry
From Behind the Markets   |   Ad
A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.
Don't miss out on the "next Ozempic" >>>

PHO Insider Trading

Insider Ownership Percentage: 54.35%
Insider Buying (Last 12 Months): A$2,190.00
Insider Selling (Last 12 Months): A$0.00

PhosCo Insider Trading History Chart

This chart shows the insider buying and selling history at PhosCo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PhosCo Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 02/2/2022 10:08 AM ET

This chart shows the closing price history over time for PHO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Could this Tiny Biotech End Disease Forever?
From Behind the Markets   |   Ad
Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.
Access my full "Cut & Paste" profit analysis now.

PhosCo Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2024Tarecq (Taz) AldaoudInsiderIssued200,000A$1.00A$200,000.00
8/24/2023Tarecq (Taz) AldaoudInsiderBuy30,000A$0.07A$2,190.00
8/5/2022Robin WiddupInsiderBuy222,222A$0.10A$22,222.20
7/15/2022Tarecq (Taz) AldaoudInsiderExpiry2,400,000A$0.14A$324,000.00
3/4/2022Robin WiddupInsiderTransfer93,333A$0.09A$8,119.97
2/14/2022Robin WiddupInsiderIssued1,717,123A$0.11A$180,297.92
1/27/2022Simon EleyInsiderIssued935,427A$0.08A$74,834.16
1/25/2022Tarecq (Taz) AldaoudInsiderIssued1,000,000A$0.10A$98,000.00
See Full Table
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
From Smallcaps Daily   |   Ad
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Click to read

SEC Filings (Institutional Ownership Changes) for PhosCo (ASX:PHO)

18.84% of PhosCo stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

PhosCo Ltd, together with its subsidiaries, engages in the exploration and development of resource projects in North Africa. The company explores for zinc and lead deposits. It holds 100% interest in the Zeflana project that consists of three permits covering a total area of approximately 78 square kilometers located in Tunisia; and 100% interest in the Djebba and Djebba 2 projects situated in Tunisia. The company was formerly known as Celamin Holdings Limited and changed its name to PhosCo Ltd in January 2022. PhosCo Ltd was incorporated in 2009 and is based in Melbourne, Australia.
Read More on PhosCo

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of PhosCo?

PhosCo's top insider shareholders include:
  1. Robin Widdup (Insider)
  2. Tarecq (Taz) Aldaoud (Insider)
Learn More about top insider investors at PhosCo.
The Weight Loss Pill That Could Disrupt a $32 Billion Industry
From Behind the Markets   |   Ad
A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.
Don't miss out on the "next Ozempic" >>>